På grund af muligheden for alvorlige bivirkninger af TRISENOX hos børn, der ammes, skal amningen ophøre forud for og under behandlingen.
Because of the potential for serious adverse reactions in nursing infants from TRISENOX, breastfeeding must be discontinued prior to and throughout administration.